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Frank von Sonnenburg, Louis Loutan,  
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for the GeoSentinel Surveillance Network1
Data collected by the GeoSentinel Surveillance Net-
work for 1,415 ill travelers returning from Indian Ocean 
islands during 1997–2010 were analyzed. Malaria (from 
Comoros and Madagascar), acute nonparasitic diarrhea, 
and parasitoses were the most frequently diagnosed infec-
tious diseases. An increase in arboviral diseases reflected 
the 2005 outbreak of chikungunya fever.
The outbreak of chikungunya fever in Indian Ocean islands (IOI) provides new insights on emerging in-
fections in this geographic region (1). We present data 
collected over 14 years from travelers to IOI who visited 
GeoSentinel clinics.
The Study
GeoSentinel sites are specialized travel clinics pro-
viding surveillance data for ill travelers. Detailed methods 
for recruitment of patients for the GeoSentinel database 
are described elsewhere (2). Demographics, travel charac-
teristics, and individual medical data were obtained from 
travelers to Comoros (including Mayotte), Madagascar, 
Maldives, Mauritius, Réunion Island, and Seychelles dur-
ing March 1, 1997–December 31, 2010. Statistical sig-
nificance was determined by using Fisher exact test for 
categorical variables and Kruskal-Wallis test for quantita-
tive variables. A 2-sided significance level of p<0.05 was 
considered significant.
This study comprised 1,415 ill patients (Table 1). De-
mographic data varied according to the visited island. Me-
dian age was 36 years, and the male to female ratio was 
1.1:1.0. The most common reason for travel was tourism 
(44.5%), followed by visiting friends and relatives (VFR) 
(30.8%). Only 43.0% of travelers had a pre-travel encoun-
ter with a travel medicine specialist or general practitioner.
Illness patterns varied by place of exposure (Figure 
1). Malaria, the most frequently diagnosed illness (388 
[27.4%] travelers), accounted for 74.1% of diagnoses for 
VFR but only 6.6% for non-VFR travelers (p<0.01). Plas-
modium falciparum malaria represented 88.0% of cases, in-
cluding 12 cases of severe malaria, mostly from Comoros 
or Madagascar. One case of P. ovale malaria was reported 
from Mauritius in a person who had previously traveled 
to Cameroon.
Arboviral disease diagnoses included 40 cases of chi-
kungunya and 24 cases of dengue. Overall, arboviral dis-
eases accounted for 4.5% of the total diagnoses. Arbovi-
ral diseases accounted for 36.0% of diseases acquired by 
travelers to Réunion Island (vs. 3.6% in non–Réunion Is-
land travelers, p<0.01) and were more frequent in tourists 
than in nontourists (6.5% vs. 2.9%, p<0.01). Numbers of 
arboviral diseases showed a sustained increase and peaked 
in 2006. Dengue was noted only after 2001. Chikungunya 
cases dramatically increased in 2006 and were sustained at 
a lower level during 2007–2010, suggesting local transfor-
mation from epidemic to endemic phases or better notifica-
tion of the diagnosis (Figure 2).
Parasitic infections other than malaria accounted for 
131 (9.3%) diagnoses. A higher proportion of parasitoses 
occurred in travelers to Madagascar than in persons who 
had not traveled there (21.3% vs. 2.6%, p<0.01) and in 
missionary than non-missionary travelers (18.7% vs. 7.9%, 
p<0.01). Intestinal helminths or protozoans were the most 
commonly identified parasites. Schistosomiasis (21 cases) 
was reported from Madagascar only.
Acute nonparasitic diarrhea accounted for 162 (11.5%) 
final diagnoses. Higher proportions of such diarrhea oc-
curred in travelers to Madagascar than in persons who had 
not traveled there (15.7% vs. 9.1%, p<0.01) and in travel-
ers to Maldives than in persons who had not traveled there 
(18.4% vs. 10.5%, p<0.01). In 23 (14.2%) cases, a patho-
gen was identified. Acute nonparasitic diarrhea and skin 
infections were more frequently reported in tourists than in 
nontourists (17.3% and 12.4% vs. 6.8% and 3.8%, respec-
tively [p<0.01]). The proportion of respiratory infections 
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was higher in persons traveling for business than in persons 
traveling for other reasons (11.2% vs. 5.1%, p<0.01).
Mosquito bites, food and water consumption, and 
direct contact with skin were the most frequent modes of 
disease transmission (Table 2). The proportion of mosqui-
to-transmitted diseases was higher among travelers to Co-
moros than among other travelers (80.2% vs. 10.0%, p = 
0.006). The proportion of foodborne diseases was higher 
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Table 1. Characteristics of 1,415 ill travelers returning from Indian Ocean islands, 1997–2010* 
Characteristic 
All islands, 
n = 1,415 
Madagascar, 
n = 502 
Comoros,  
n = 444 
Maldives, 
n = 174 
Mauritius, 
n = 153 
Seychelles, 
n = 81 
Réunion 
Island, n = 39 
>1 Island,  
n = 22 
Female sex, %† 47.8 47.2 42.3 51.7 51.6 63 53.8 50 
Median age, y (95% 
CI)† 
36 (19–65) 33 (20–66) 39 (18–64) 34 (6–62) 37 (15–69) 39 (24–69) 33 (14–65) 32 (23–62) 
Median travel duration, 
d (95% CI)† 
29 (7–341) 30 (8–665) 41 (12–176) 14 (5–366) 14 (6–109) 14 (7–112) 19 (2–3,270) 35 (9–416) 
Reason for travel, %†         
 Tourism 44.5 53.8 5.6 62.6 81.0 85.2 48.7 59.1 
 VFR 30.8 5.2 89.4 0 5.2 1.2 10.3 0.0 
 Missionary/ 
 volunteer/student/ 
 military 
12.9 24.7 1.4 21.9 3.3 1.2 5.1 27.3 
 Business 10.9 15.9 1.8 15.5 10.5 11.1 30.8 9.1 
 Other 0.1 0.4 1.8 0 0 1.2 5.1 4.5 
Pre-travel health 
advice, %† 
43.3 55.2 32.2 47.1 35.9 37 25.6 72.7 
Inpatient care, % 30.0 7.2 79.3 8.0 9.2 3.7 12.8 4.5 
*VFR, visiting friends and relatives. 
†p<0.01 for the comparison among islands. 
 
Figure 1. Relative proportion of different diagnoses among 1,415 ill travelers returning from Indian Ocean islands, 1997–2010. The 
numbers are shown for each diagnosis for all ill travelers returning from each island. Some patients had >1 diagnosis. Malaria: Plasmodium 
falciparum infection (341 cases, including 12 severe cases), P. vivax infection (24), P. ovale infection (11), P. malariae infection (10). 
Acute diarrheal infections: campylobacteriosis (12), salmonellosis (6), shigellosis (5). Parasitic infections: gardiasis (33), schistosomiasis 
(21), strongyloidiasis (13), miyases (13), amoebiasis (9), cutaneous larva migrans (9), trichuriasis (7), ascariasis (5), hookworm infection 
(5), enterobiasis (2), neurocysticercosis (2), filariasis (1), blastocystosis (1). Respiratory infections: upper respiratory tract infections 
(26), influenza (6), tuberculosis (4). Arboviral infections: chikungunya (40), dengue (24). Other infections: urinary tract infections (22), 
leptospirosis (2), rickettsial infections (3), Q fever (1). Among accidental diseases: insect bites (28), rabies postexposure treatments (6), 
marine envenomization (5).
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among travelers to Madagascar than in travelers to other 
areas (27.5% vs. 10.9%, p<0.001) and to Maldives than to 
other areas (23.0% vs. 15.8%, p = 0.03). Diseases transmit-
ted through skin contact accounted for a higher proportion 
of diagnoses in travelers returning from Madagascar than 
from other areas (18.1% vs. 7.6%, p<0.001). Compared 
with nonbusiness travelers, business travelers had a higher 
proportion of respiratory-transmitted diseases (1.9% vs. 
12.3%, p<0.001) and sexually and blood-transmitted dis-
eases (0.3% vs. 6.6%, p = 0.03).
Conclusions
This large study addresses travel-associated diseases 
in travelers returning from IOI. P. falciparum infection 
was the most common reason for seeking post-travel care, 
notably when returning from Comoros, a well-known 
malaria-endemic archipelago (3). Imported malaria is 
frequently described in France, particularly in Marseille, 
which is the preferred residence city for migrants from 
Comoros and their descendants (4). Previous reports have 
shown that VFR sought pre-travel advice less frequently 
than did other travelers, possibly because of economic 
concerns, language barriers, or cultural beliefs (5–7). We 
observed a lower proportion of malaria in persons who had 
traveled to Madagascar, where both P. falciparum and P. 
vivax are endemic, and only 1 case in a traveler to Mau-
ritius, where few cases are reported (3). No malaria cases 
were identified from Réunion Island, Seychelles, or Mal-
dives, which is consistent with travel medicine guidelines 
that do not recommend chemoprophylaxis for travelers 
visiting these islands (8).
The reports of dengue and chikungunya fever from all 
islands reflect the wide distribution of the vector, Aedes 
spp. mosquitoes. Our results parallel those of the chikun-
gunya fever outbreak that spread throughout IOI during 
2005–2006 (9), facilitated by an adaptive virus mutation 
that led to increased infectivity, replication, and transmis-
sion by A. albopictus mosquitoes (10). The outbreak af-
fected hundreds of travelers to IOI (11). Concern about the 
possible spread of chikungunya fever increased with the 
autochthonous outbreak of chikungunya fever in Italy in 
2007 that developed from a patient returning from India 
(12). This sporadic case confirmed the ability of the virus 
to settle in countries colonized by Aedes sp. mosquitoes as 
a result of increasing intercontinental exchanges. Surveil-
lance of travelers with a view toward early diagnosis is a 
key element in controlling outbreaks of imported arboviral 
diseases.
Parasitic infections, including schistosomiasis, ac-
counted for a major proportion of final diagnoses in travel-
ers to Madagascar, where these infections represent a pub-
lic health concern (13). Testing for such diseases should be 
considered in ill travelers returning from this island.
Nonparasitic diarrhea was reported mainly in tourists 
returning from Madagascar and the Maldives. Few patho-
gens were documented, reflecting the practice of empiric 
antimicrobial treatment before laboratory testing (14). The 
higher incidence of diarrheal illness among tourists could 
be explained by an immature mucosal immunity (15) and 
easier access to medical care.
Business travelers had a higher proportion of respira-
tory diseases, independent of the island visited. This find-
ing may relate to longer stays in air conditioned hotels and 
close human-to-human contact in this population.
These data have at least 4 limitations. First, we in-
cluded only returning travelers who were ill and receiving 
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Figure 2. Annual occurrence 
of arboviral disease cases 
(dengue and chikungunya) 
among 1,415 travelers returning 
from Indian Ocean islands and 
seen at GeoSentinel sites, 
1997–2010.
care at GeoSentinel sites. Second, self-limited diseases or 
diseases of short duration may be underrepresented. Third, 
the lack of a denominator does not permit calculation of 
prevalence. Fourth, diseases with very short or very long 
incubation periods might not, with certainty, be attributed 
to any particular destination. Nevertheless, our study de-
scribes the spectrum of diseases among travelers returning 
from each IOI based on robust numbers of ill travelers.
Ill travelers returning from IOI are heterogeneous in 
their demographic and travel characteristics and display 
specific diseases that depend on the island and the travel 
reason. These findings reflect the different economic, eco-
logic, and public health situations found across this region 
(online Technical Appendix Table, wwwnc.cdc.gov/EID/
article/19/8/12-1739-Techapp1.pdf). More than two thirds 
of diseases in travelers to IOI were, theoretically, prevent-
able by reinforcing food and hand hygiene and by avoiding 
insect bites or direct contact with soil and fresh water. Most 
travelers in our survey traveled to a single island; thus, tar-
geted destination-specific pre-travel advice and post-travel 
medical management of ill persons should be provided on 
a country-level basis rather than addressed nonspecifically.
Additional members of the GeoSentinel Surveillance Net-
work who contributed data (in descending order) are as follows: 
Philippe Parola and Jean Delmont, University Hospital Institute 
Méditerranée Infection, Marseille, France; François Chappuis, 
University of Geneva, Geneva, Switzerland; Prativa Pandey and 
Holly Murphy, CIWEC Clinic Travel Medicine Center, Kath-
mandu, Nepal; Eric Caumes and Alice Pérignon, Hôpital Pitié-
Salpêtrière, Paris, France; Gerd-Dieter Burchard, Bernhard-
Nocht-Institute for Tropical Medicine, Hamburg, Germany; 
Michael D. Libman, Brian Ward, and J. Dick Maclean, McGill 
University, Montreal, Quebec, Canada; Jay S. Keystone and 
Kevin Kain, University of Toronto, Toronto, Ontario, Canada; 
Karin Leder, Joseph Torresi, and Graham Brown, Royal Mel-
bourne Hospital, Melbourne, Victoria, Australia; DeVon C. Hale, 
Rahul Anand, and Stephanie S. Gelman, University of Utah, 
Salt Lake City, Utah, USA; Shuzo Kanagawa, Yasuyuki Kato, 
and Yasutaka Mizunno, International Medical Center of Japan, 
Tokyo, Japan; Phyllis E. Kozarsky, Jessica Fairley, and Carlos 
Franco-Paredes, Emory University, Atlanta, Georgia, USA; Nat-
suo Tachikawa, Hanako Kurai, and Hiroko Sagara, Yokohama 
Municipal Citizen’s Hospital, Yokohama, Japan; Sarah Borwein, 
TravelSafe Medical Centre, Hong Kong, China; Bradley A. Con-
nor, Cornell University, New York, New York, USA; Patricia 
Schlagenhauf, Rainer Weber, and Robert Steffen, University 
of Zürich, Zürich, Switzerland; Giampiero Carosi, University 
of Brescia, Brescia, Italy; Eli Schwartz, Chaim Sheba Medical 
Center, Tel Hashomer, Israel; Effrossyni Gkrania-Klotsas, Ad-
denbrooke’s Hospital, Cambridge, UK; Mogens Jensenius, Oslo 
University Hospital, Oslo, Norway; Peter de Vries and Kartini 
Gadroen, University of Amsterdam, Amsterdam, the Netherlands; 
Watcharapong Piyaphanee and Udomsak Silachamroon, Mahidol 
University, Bangkok, Thailand; Marc Mendelson and Peter Vin-
cent, University of Cape Town and Tokai Medicross Travel Clin-
ic, Cape Town, South Africa; N. Jean Haulman, David Roesel, 
and Elaine C. Jong, University of Washington and Harborview 
Medical Center, Seattle, Washington, USA; Robert Kass, Trav-
ellers Medical and Vaccination Centres of Australia, Adelaide, 
South Australia, Australia (December 1997–March 2001 only); 
Noreen A. Hynes, R. Bradley Sack, and Robin McKenzie, Johns 
Hopkins University, Baltimore, Maryland, USA; Alejandra Gurt-
man, Mount Sinai Medical Center, New York (October 2002–
August 2005 only); Christophe Rapp and Olivier Aoun, Hôpital 
d’instruction des armées Bégin, Saint Mandé, France; Robert 
Muller, Travel Clinic Services, Johannesburg, South Africa (May 
2004–June 2005 only); Thomas B. Nutman and Amy D. Klion, 
National Institutes of Health, Bethesda, Maryland, USA; Jose An-
tonio Perez Molina, Ramón y Cajal Hospital, Madrid, Spain; Lin 
H. Chen and Mary E. Wilson, Mount Auburn Hospital, Harvard 
University, Cambridge, Massachusetts, USA; Nicole Anderson, 
Trish Batchelor, and Dominique Meisch, International SOS Clin-
ic, Ho Chi Minh City, Vietnam; William M. Stauffer and Patricia 
F. Walker, University of Minnesota, Minneapolis, Minnesota, 
USA; Carmelo Licitra and Antonio Crespo, Orlando Regional 
Health Center, Orlando, Florida, USA; Annelies Wilder-Smith, 
Tan Tock Seng Hospital, Singapore; Annemarie Hern, Worldwise 
Travellers Health and Vaccination Centre, Auckland, New Zea-
land; Andy Wang, Jane Eason, and Susan MacDonald, Beijing 
United Family Hospital and Clinics, Beijing, China; Anne Mc-
Carthy, University of Ottawa, Ottawa, Ontario, Canada; John D. 
Cahill and George McKinley, St. Luke’s-Roosevelt Hospital Cen-
ter, New York; Patrick Doyle and Wayne Ghesquiere, Vancouver 
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Table 2. Modes of disease transmission for 1,415 ill travelers returning from Indian Ocean islands, 1997–2010 
Mode of transmission 
Total no. (%), 
n = 1,415 
Island visited, no. (%) travelers 
Madagascar, 
n = 502 
Comoros, 
n = 444 
Maldives, 
n = 174 
Mauritius, 
n = 153 
Seychelles, 
n = 81 
Réunion 
Island, n = 39 
>1 Island, 
n = 22 
Mosquito bite 452 (31.9) 48 (9.6) 356 (80.2) 17 (9.8) 13 (8.5) 4 (4.9) 14 (35.9) 0 (0.0) 
Food/water 
consumption 
236 (16.7) 138 (27.5) 10 (2.3) 40 (23.0) 27 (17.6) 20 (24.7) 3 (7.7) 2 (9.1) 
Direct skin contact 159 (11.2) 91 (18.1) 9 (2.0) 20 (11.5) 24 (15.7) 17 (21.0) 0 2 (9.1) 
Respiratory droplet  102 (7.2) 33 (6.6) 25 (5.6) 20 (11.5) 15 (9.8) 7 (8.6) 8 (20.5) 4 (18.2) 
Animal contact 44 (3.1) 15 (3.0) 0 7 (4.0) 10 (6.5) 12 (14.8) 1 (2.6) 1 (4.5) 
Fresh water contact 23 (1.6) 21 (4.2) 0 0 1 (0.7) 0 1 (2.6) 0 
Sex/blood 7 (0.5) 3 (0.6) 1 (0.2) 1 (0.6) 0 1 (1.2) 1 (2.6) 0 
Tick bite 3 (0.2) 1 (0.2) 1 (0.2) 0 1 (0.7) 0 0 0 
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General Hospital and Vancouver Island Health Authority, Van-
couver and Victoria, British Columbia, Canada; Elizabeth D. Bar-
nett, Boston University, Boston, Massachusetts, USA; Michael 
W. Lynch, Fresno International Travel Medical Center, Fresno, 
California, USA (August 2003–February 2010 only); Luis M. 
Valdez and Hugo Siu, Clínica Anglo Americana, Lima, Peru; and 
Susan McLellan; Tulane University, New Orleans, Louisiana, 
USA (December 1999–August 2005 only).
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